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ABSTRACT 30 
Hypothesis. Wound healing is a complex process that often requires treatment with antibacterial 31 
agents to avoid infection, which affects the optimal tissue regeneration process. Ideal scaffolds for 32 
wound healing treatment should combine biomimetic features to ensure the tissue growth on 33 
properly designed extracellular matrix (ECM)-like scaffolds and antibacterial properties in order 34 
to avoid bacterial colonization.  35 
Experiments. In this work, gelatin cross-linked nanofibers (GL-nanofibres), with diameters 36 
ranging from 200 to 300 nm, were prepared via a “green electrospinning technique” to mimic the 37 
structure and composition of the extracellular matrix (ECM), and promote the normal skin wound 38 
healing process. Nanofibres were doped with two antibacterial agents (gentamicin sulphate or 39 
silver nanoparticles) to achieve an antibacterial effect against Gram+ and Gram- bacteria.  40 
Findings. The ECM-mimicking structure of GL-nanofibres was not affected by the presence of 41 
the antibacterial agents, which were homogeneously distributed within the mats as shown by SEM 42 
and EDS. The antibacterial properties of the developed matrices were confirmed using 4 strains 43 
(S. aureus, S. epidermidis, P. aeruginosa and E. coli) while the biocompatibility of the developed 44 
substrates and their ability to induce cell growth was assessed using Neonatal Normal Human 45 
Dermal Fibroblasts (NHDF-Neo). 46 
 47 
KEYWORDS: antibacterial nanofibers, electrospinning, ECM-like scaffolds, gentamicin, 48 
silver nanoparticles, gelatin, wound healing 49 
 50 
 51 
 52 
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1. Introduction 53 
Wound healing is a dynamic, interactive, multicellular process involving extracellular matrix 54 
(ECM), cytokines, blood cells, parenchymal cells, etc [1]. During wound healing, five overlapping 55 
stages occur: hemostasis, inflammation, proliferation, contraction, and remodelling [2]. The 56 
prevention of wound infection during this process is a major challenge that needs a solution 57 
urgently, because high microbial colonization at the wound site delays the wound healing and in 58 
long-term it can lead to life-threatening conditions [3]. In this attempt, wound care dressings have 59 
been largely investigated with the aim to maintain favourable conditions for the healing process 60 
and to protect the wound from environmental threats and penetration of bacteria. Different 61 
materials, such as cotton, honey, animal fats, and vegetables fibres, have been used for wound 62 
dressings [4, 5]. However, these conventional treatments may have many drawbacks such as strong 63 
adherence to the wound, need of frequent replace and presence of microorganisms or chemicals 64 
which might be detrimental to a proper wound healing. Therefore, electrospun polymer mats have 65 
emerged for their great potential as wound dressing materials due to their close structural 66 
resemblance to the ECM (which enhances the tissue growth), their high porosity that allows gas 67 
permeation, and the large surface to volume ratio which provides an open structure for drainage of 68 
exacerbated exudate and hemostasis enhancement [6]. Hence, biodegradable polymer nanofibres 69 
with different chemical and physical properties using both - synthetic polymers such as 70 
polyurethanes [7-9], poly(caprolactones) [10, 11] and poly(vinyl alcohols) [10, 12, 13] and natural 71 
polymers such as collagen [14], gelatin [7, 15], silk fibroin [16, 17] and chitosan [16, 18] have 72 
been applied for wound healing having bioresorption as major advantage compared to non-73 
degradable polymers. 74 
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Among natural polymers, gelatin (GL) is a protein derived from partial hydrolysis of native 75 
collagens, which are the most abundant structural proteins found in the animal body on skin, 76 
tendons, cartilage and bones [19]. GL has been widely used for engineering tissues, dressings for 77 
wound healing, and drug delivery because of its similarity, as adhesive protein, to the more 78 
expensive collagen [20-23]. GL has been also found to provide hemostasis and promote cell 79 
adhesion and proliferation during wound healing [24]. However, poor mechanical properties and 80 
low thermal stability, limits the biomedical application of this material which can be improved by 81 
cross-linking [25-27] and/or combining with other more stable polymers [7, 21, 28]. Research 82 
efforts for further improvement of GL nanofibrous matrices have been mainly targeting 83 
functionalization with pharmaceutical [29, 30] and bioactive agents [30-35] as well as drug release 84 
modulation. Incorporated drugs and proteins play an active role in the wound healing process, 85 
either directly or indirectly, as cleansing or debriding substances to remove necrotic tissue as 86 
antibacterial agent to prevent or treat infections, or as bioactive molecules (e.g. growth factors) to 87 
aid tissue regeneration. Moreover, the development of medicated dressing aims to prolong the 88 
action of active agents over time by allowing sustained release from a nanofibrous polymeric 89 
matrix without the need for frequent dressing change, depending on the severity of the wound [36]. 90 
In the current work, GL nanofibrous matrices loaded with the antibacterial drug gentamicin 91 
sulphate (GS) or silver nanoparticles (AgNPs), were fabricated to induce a potent  antibacterial 92 
effect against Gram+ and Gram- bacteria and to guarantee a controlled release of the antibacterial 93 
during time and space via the high surface area to volume ratio of the nanofibre system during 94 
tissue healing process. Furthermore, the topical local delivery from a bioresorbable nanofibrous 95 
matrix may reduce the risk associated to over toxicity and systemic toxicity targeting only the 96 
infection site [37]. GS and AgNPs were selected due to their antibacterial activity against both 97 
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Gram+ and Gram- bacteria [38]. GS is a widely used aminoglycoside antibiotic. It is heat-stable, 98 
making it an ideal candidate for a range of fabrication and incorporation methods, which require 99 
temperatures higher than the physiological condition (about 37 °C). Silver (Ag) has been 100 
commonly applied for the treatment of burns and chronic wounds as an alternative to antibiotics, 101 
since the cases of bacterial resistance to currently used antibiotics has been increasing. Dressings 102 
designed to elute silver ions have been shown to be effective at reducing bacterial colonisation of 103 
wounds [19, 39, 40] as ointment and cream (silver sulfadiazine) [41], or it can be loaded in matrices 104 
as nanoparticles for its controlled release [42, 43]. Several products incorporate silver for use as a 105 
topical antibacterial agent, such as silver nitrate, silver sulphadiazine (Flammazine™) [44], silver 106 
sulphadiazine/chlorhexidine (Silverex®,), and silver sulphadiazine-impregnated lipidocolloid 107 
wound dressing Urgotul SSD® [40, 45]. Further, AgNPs show more efficient antibacterial 108 
properties than other salts due to their extremely large surface area, which provides better contact 109 
with microorganisms [46, 47].  110 
The GL crosslinked nanofibres doped with antibacterial agents were obtained using an 111 
environmental and cell friendly method (“green electrospinning”) as only water was used as 112 
solvent within all the process. The fabrication process was set up in order to crosslink the GL 113 
nanofibers within the fabrication process avoiding a second step which could affect the 114 
nanofibrous mat morphology and consequently its biomimetic properties. 115 
Developed nanofibers were analysed for their physicochemical and morphological properties by 116 
scanning electron microscopy (SEM) and Energy dispersive X-ray spectrometer (EDS), 117 
transmission electron microscopy (TEM) and their mechanical properties were evaluated by tensile 118 
tests.  GS release from GL nanofibres membranes was evaluated by means of UV-VIS 119 
spectroscopy, whilst the AgNPs release was indirectly investigated from the antibacterial test 120 
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results conducted in vitro against four different bacterial species. Finally, Neonatal Normal Human 121 
Dermal Fibroblasts (NHDF-Neo) were seeded on the surface of electrospun membranes in order 122 
to test the cytocompatibility and explore their further application in tissue engineering. 123 
 124 
2. Materials and methods 125 
2.1 Materials 126 
GL (type A from porcine skin), (3-Glycidyloxypropyl)trimethoxysilane (GPTMS), GS and silver 127 
nitrate were supplied by Sigma Aldrich. 128 
 129 
2.2 Sample preparation 130 
2.2.1 Preparation of solutions for electrospinning 131 
The GL solutions with improved antibacterial properties, coded as GL/GS and GL/AgNPs 132 
according to the antibacterial agent incorporated, were prepared as follows: 133 
- GL/AgNPs: 2.5% or 5% w/w AgNO3 (based on the weight of the GL powder) were dissolved 134 
in demineralised water, followed by GL addition to the solution (15% wt/v). The AgNO3-135 
containing GL solution was aged in an amber glass bottle while being stirred at 50°C for 18 h. 136 
The reduction of Ag+ ions into elemental Ag (i.e., nAg) in the AgNO3-containing GL solutions 137 
was visualized by changes in the color of the solutions: from light yellow of the GL solution to 138 
brown of the 18 h-aged AgNO3-containing solution (reported as Supporting Information, Fig. 139 
S1). In this work an ageing time of 18h was selected to achieve AgNP formation avoiding GL 140 
hydrolytic degradation. As previously reported by Rujitanaroj et al., the amount of AgNP 141 
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formed by AgNO3 reduction increased monotonically with increasing aging time until 10 days. 142 
However, the GL hydrolytic degradation occurred for a mixing period longer than 2 days [15].  143 
- GS loaded solutions (GL/GS) were prepared by dissolving GL (15% wt/v) and GS in distilled 144 
water at 50°C and mixed together to obtain blends with weight ratios of GS to GL of 2.5, 5, 7.5 145 
and 10% w/w. Solutions were left under magnetic stirring at 50°C for about 40 minutes. 146 
GL solution without the addition of antibacterial agents was prepared following the procedures 147 
described above and used as control. 148 
Finally, an appropriate amount of GPTMS crosslinker was added to GL/AgNO3, GL/GS and GL 149 
solutions and mixed for 1 h before spinning. The amount of GPTMS was calculated with respect 150 
to the molar concentration of amino groups in hydroxylysine, lysine and arginine residues of GL 151 
to obtain a molar ratio of 2:1 between the GL amino groups and the GPTMS molecules according 152 
to literature [48-50].  153 
2.2.2 Electrospinning of GL nanofibres 154 
Nanofibrous matrices were prepared by the electrospinning using a flat aluminium plate to collect 155 
randomly oriented nanofibres. The electrospinning system used (Biomedical Components s.r.l) for 156 
fibre preparation consists of a high voltage generator (PS/EL30R01.5-22 Glassman High Voltage); 157 
a volumetric pump (KDS210 of KD Scientific); a mobile syringe support and a collector as 158 
previously described [49]. Spinning parameters were set as voltage of 30 kV and a flow rate of 15 159 
µl/min. Furthermore, the electrospinning apparatus was placed into a temperature-controlled 160 
chamber and the temperature was set at 50°C to avoid GL solution gelation within the needle 161 
during the electrospinning process. After spinning, all CS nanofibres were peeled off from the 162 
collector and characterized. 163 
 164 
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 166 
2.3 Morphological characterization through electron microscopy 167 
2.3.1 Scanning electron microscopy (SEM) equipped with an energy dispersive X-ray 168 
spectrometer (EDS) 169 
The fibre morphology of GL loaded nanofibres was observed by scanning electron microscopy 170 
(SEM LEO – 1430, Zeiss) at 20 kV. Using EDS, qualitative compositional analysis was performed 171 
and punctual elemental composition of materials was accomplished. Samples were sputter coated 172 
with gold in an under vacuum chamber prior to SEM-EDS examination. SEM micrographs were 173 
then analysed through ImageJ1.44g software. Fibre diameters were measured on three different 174 
SEM micrographs (50 measures were taken for each image) and reported as average value ± 175 
standard deviation. 176 
2.3.2 Transmission electron microscopy (TEM) 177 
The silver nanoparticles formation and incorporation into GL based nanofibres were determined 178 
using a Libra 120 TEM (Zeiss). TEM samples were prepared by dispersing small bundles of fibres 179 
in ethanol using an ultrasonic bath for 10 minutes. Then, the obtained solutions were deposited on 180 
a 300 mesh carbon coated TEM grid. 181 
 182 
2.4 Fourier transform infrared-attenuated total reflectance spectroscopy (FTIR-ATR) 183 
Chemical analysis of GL, GL/AgNPs and GL/GS nanofibrous matrices was performed by FTIR-184 
ATR spectroscopy (Perkin-Elmer) over a range of 4000 cm−1– 600 cm−1 at a resolution if 4 cm-185 
1 and 16 scans. 186 
 187 
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 189 
2.5 Static water contact angle 190 
Static contact angles of water on the nanofibre nonwoven surfaces were measured using the sessile 191 
drop method with a KSV instrument. Five µl of deionized water was dropped onto dry samples in 192 
air and the contact angle was calculated using a CAM200 Software. For each angle reported, at 193 
least five measurements on different surface locations were measured and results were expressed 194 
as average value ± standard deviation. As GL is a swellable material the contact angle value was 195 
collected immediately after drop deposition to avoid water adsorption.  196 
 197 
2.6 Mechanical properties 198 
The tensile mechanical properties were evaluated on nanofibrous membranes in dry condition by 199 
using a MTS QTest/10 device equipped with a load cell of 10 N. Rectangular strips of 20 mm × 200 
10 mm size were cut from each sample and strained to break at a constant crosshead speed of 2 201 
mm/min. Sample thickness was measured by using a Vernier digital calibre, obtaining values in 202 
the range of 110–140 μm. Using the associated software Test Works, break stress and strain were 203 
determined. The Young’s modulus (E), ultimate tensile strength (UTS) and strain at failure (ε 204 
failure) were calculated from the stress–strain curve.  Five specimens for each membrane were 205 
tested and results were expressed as average values ± standard deviation. 206 
 207 
2.7 Antibacterial agent release quantification 208 
GS release from GL/GS nanofibrous membranes were carried out by UV–VIS spectroscopy 209 
(CARY 500 SCAN UV–VIS–NIR Spectrophotometer). Samples were immersed in 3 ml of PBS 210 
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(pH 7.4) and GS concentration in the incubation media was measured after 1, 3, 6, 9 and 24 hours. 211 
The GS release concentration was reported as a percentage respect to the initial concentration and 212 
it was calculated from the absorption values using the calibration curves that were prepared starting 213 
from GS solutions of known concentrations. UV spectra were recorded in a range of 4000–600 214 
nm.  215 
On the other hand, Ag+ release was quantified by means of Inductively Coupled Plasma Atomic 216 
Emission Spectrometry Technique (ICP-AES) (ICP-MS, Thermoscientific, ICAP Q), after 217 
appropriate dilutions. Two ml of milliQ water were added to 4 mg of each sample and supernatants 218 
were collected after 1, 6, 24 and 168 hours.  219 
Five measures for sample were used and the data was reported as mean value ± standard deviation. 220 
 221 
2.8 Antibacterial activity of GL/GS and GL/AgNPs nanofibres  222 
2.8.1 Disk diffusion method 223 
Diffusion method was selected as screening assay to verify the antibacterial effectiveness of 224 
different types of electrospun nanocomposite fibrous matrices. Antibacterial activity of GL, 225 
GL/AgNPs, GL/GS nanofibrous membranes (5 mm sides squares previously sterilized by 30 226 
minutes UV treatment) was tested against Gram-positive Staphylococcus aureus (ATCC 25923), 227 
Staphylococcus epidermidis (ATCC 12228) and Gram-negative Pseudomonas aeruginosa (ATCC 228 
10145), Escherichia coli (ATCC 25922) based on EUCAST guidelines [51], with some 229 
modifications. Briefly, Mueller-Hinton agar was used as bacterial growth medium. The agar 230 
surface was inoculated by using a swab dipped in a cell suspension of a 0.5 McFarland turbidity 231 
standard, approximately corresponding to 1-2108 Colony Forming Unit per ml (CFU/ml). All 232 
nanofibrous membranes were placed on each S. aureus, S. epidermidis, P. aeruginosa and E. coli 233 
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inoculated agar plate and incubated at 37 °C for 24 hours. Afterwards, the inhibition zone 234 
diameters were measured.  235 
2.8.2 MTT colorimetric assay 236 
The cytotoxicity of GS and AgNPs loaded nanofibres was assessed using 3-[4,5-dimethylthiazol-237 
2-yl]-2,5-diphenyltetrazolium bromide (MTT)-based colorimetric assay [52]. Bacterial 238 
suspensions at a concentration of 5105 CFU/ml were prepared in Tryptic Soy Broth (TSB) for S. 239 
aureus, S. epidermidis, P. aeruginosa and in Luria Bertani Broth for E. coli. Afterwards, 1 ml of 240 
each of these suspensions was used to dip 2 mg of GL, GL/AgNPs, GL/GS nanofibrous membranes 241 
(previously sterilized by 30 minutes UV treatment in 5 ml tubes) and samples were incubated at 242 
37° C for 24, 48 and 72 hours at 100 rpm. At the end of each incubation time, bacteria were 243 
harvested by centrifugation at 12000 rpm for 10 minutes and incubated for 30 minutes in 1 ml of 244 
MTT working solution [0.03 g of MTT (Sigma-Aldrich) in 9.85 ml of PBS supplemented with 50 245 
μl of a 20% glucose solution and 100 μl of a 1 mM menadione solution]. Bacteria were then 246 
harvested by centrifugation at 12000 rpm for 10 minutes and resuspended in 1 ml of 247 
DMSO:glycine 0.1 M pH 10.2 (7:1) buffer. Finally, absorbance of each sample was measured by 248 
spectrophotometric reading at 570 nm wavelength. The percentage of inhibition of GL/AgNPs, 249 
GL/GS samples, compared to GL membranes (controls), was determined as: 250 
                             [1-(Abstreat/Absctrl)] × 100                           (1) 251 
Where: 252 
Abstreat; optical density of treated samples 253 
Absctrl; optical density of controls. 254 
 255 
2.9 Biological tests 256 
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Neonatal Normal Human Dermal Fibroblasts (NHDF-Neo) were purchased from Lonza 257 
Biosciences (Switzerland) and cultured as recommended by the seller. Briefly, fibroblasts were 258 
grown at 37 °C, 5% CO2, in Dulbecco’s Modified Eagle Medium (DMEM, Sigma) supplemented 259 
with 10% fetal bovine serum (FBS), 2 mM L-glutamine and a 1% antibiotic mixture containing 260 
penicillin and streptomycin (100 U mL-1). 261 
In order to perform biocompatibility assays, the electrospun membranes (15 mm diameter) were 262 
mounted in 24-multiwell cell crowns (Scaffdex, Finland) and UV-sterilized for 15 min. A 263 
suspension of 1.5 x 104 cells in DMEM was seeded dropwise on the top surface of the membranes 264 
and incubated at 37 °C, 5% CO2 for 30 min. Then, fresh DMEM was added up to 1 mL volume. 265 
2.9.1 Cytocompatibility studies 266 
Cell viability was assessed with the live/dead staining (LIVE/DEAD® Cell Imaging Kit, Life 267 
Technologies, Thermo Scientific, USA) at 24 and 48 hours. According to the manufacturer’s 268 
protocol, membranes were washed with phosphate buffered saline (PBS, Sigma-Aldrich, UK) and 269 
stained with 150 µL solution of 4 µM Ethidium homodimer-1 and 2 µM calcein in PBS. After 35 270 
minutes of incubation at room temperature, cells were imaged with a Leica DM/LB fluorescence 271 
microscope to detect calcein (ex/em 488 nm/515 nm) and Ethidium homodimer-1 (ex/em 570 272 
nm/602 nm), respectively.  273 
Furthermore, the Presto Blue assay was exploited to test the metabolic activity of cells seeded on 274 
the different nanofibrous mats after 1 and 4 days of culture. A LS-50B Luminescence Spectrometer 275 
(Perkin Elmer, Waltham, MA) was used to measure the fluorescence (560nm excitation and 590nm 276 
emission) after 1.30 h of incubation with a 10% aliquot of Presto Blue (Thermo Scientific, USA). 277 
Results were expressed as mean ± standard deviation.  278 
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Finally, the cell morphology was observed by nucleus and cytoskeleton staining. Briefly, cells 279 
were fixed with 4% paraformaldehyde solution for 15 minutes, followed by three washing steps 280 
with PBS. Cells were then permeabilised using 0.1% v/v Tween20® in PBS for 5 minutes. 281 
Rhodamine-phalloidin was prepared using 1:100 dilution of phalloidin-tetramethylrhodamine B 282 
isothiocyanate (Sigma Aldrich, P1951) in 1% v/v Tween20® in PBS for 30 min, and then washed 283 
three times with PBS. One drop of DAPI (VECTASHIELD®) antifade mounting media was added 284 
to each sample, then covered with a glass slide and imaged using a Leica DM/LB fluorescence 285 
microscope. 286 
 287 
2.10 Statistical analysis 288 
Experiments were repeated three times and results expressed as a mean ± standard deviation. 289 
Statistical significance was calculated using analysis of variance (ANOVA). A comparison 290 
between two means was analyzed using Tukey's test with statistical significance level set at *p< 291 
0.05, **p< 0.01 and **p< 0.001. 292 
 293 
3. Results  294 
3.1 Morphological characterization through electron microscopy 295 
GL based randomly oriented fibres with an average fibre dimension of 220 nm were fabricated as 296 
previously reported [49]. Fig. 1 reports SEM images of electrospun nanofibers of GL containing 297 
different concentrations of GS. All GS loaded nanofibres scaffolds exhibited smooth, uniform and 298 
bead-less fibrous randomly interconnected structure. No drug crystals were detected by the 299 
electron microscopy on the surface or outside the fibres loaded with the antibiotic agent, 300 
demonstrating the homogeneous character of the drug/polymer solution (Supporting Information, 301 
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Fig. S2). The corresponding size distributions of the developed nanofibres are listed in Fig. 1 (right 302 
side) and a uniform distribution of fibre diameter was observed with an average diameter of 217 ± 303 
7, 206 ± 7, 184 ± 5, 208 ± 5 and 216 ± 7 nm for pure GL, GL/GS2.5, GL/GS5, GL/GS7.5 and 304 
GL/GS10, respectively. A slight decrease in the fibre diameter was detected increasing GS 305 
concentration (except for GS amount equal to 10% w/w). This effect has to be ascribed to the 306 
incorporation of positively charged GS into the electrospinning solution, which may significantly 307 
increase the surface charge density of the spinning jet [53]. EDS analysis was performed on GL, 308 
GL/GS2.5, GL/GS5, GL/GS7.5 and CS/GS10 nanofibrous membranes to evaluate the distribution 309 
of GS in the electrospun samples. Inserts in Fig.1 (A, B, C, D and E) report the EDS element-310 
mapping on the surfaces: the green dots, corresponding to the presence of Sulfur-containing 311 
species, were uniformly dispersed on the nanofibrous surfaces of all GS loaded samples. EDS 312 
element-mapping also detected the presence of Carbon and Oxygen elements characteristic of GL 313 
and peaks corresponding to Silicon containing compounds associated to the presence of GPTMS 314 
(data not shown).  315 
Fig. 2 reports selected SEM images of electrospun nanofibrous matrices from both the 18 h-aged 316 
AgNO3-containing gelatin solutions (AgNO3 2.5 and 5 % wt/wt). Cross-sectionally round fibres, 317 
without the presence of beads, were observed. The diameters of the AgNPs2.5 and AgNPs5 loaded 318 
nanofibres obtained from these solutions were 314±12 and 277± 8nm, respectively. The fibre 319 
diameter increased when AgNO3 was added. Inserts on the top in Fig. 2 shows TEM images of 320 
nanofibrous matrices from the 18 h-aged AgNO3-containing gelatin solutions: AgNPs were found 321 
to be homogenously distributed throughout the fibres, as also confirmed by the EDS pattern of 322 
elemental Ag (insert on the bottom) with the diameters of these particles being 13 ± 4 nm. 323 
Quantitative assessment by EDS of the amount of elemental Ag in fibre matrices indicated an 324 
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augmentation in value from 0.06 to 0.12 wt% by increasing the AgNO3 amount from 2.5 to 5 % 325 
wt/wt. 326 
 327 
Fig.1 Representative SEM micrographs, fibre distribution and EDS mapping of the 328 
electrospun nanofibres loaded with various GS amounts (green dots correspond to the presence 329 
of Sulfur-containing species). Notes: A) GL, B) GL/GS2.5, C) GL/GS5, D) GL/GS7.5 and E) 330 
GL/GS10.  331 
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 332 
 333 
Fig. 2. Representative SEM images, TEM images and EDS mapping (red dots were 334 
associated to Ag) of GL/AgNPs2.5 (A) and GL/AgNPs5 fibres  335 
 336 
3.2 Fourier transform infrared-attenuated total reflectance spectroscopy (FTIR-ATR) 337 
FTIR-ATR measurements were conducted on GS GL/GS nanofibres and GL/AgNPs to determine 338 
if the introduction of GS or AgNPs formation of the electrospun nanofibres may affect the primary 339 
gelatin structure and the GPTMS crosslinking mechanism. All spectra showed an amide I peak (C 340 
= O stretch) at 1637 cm-1, amide II peak (N-H bend) at 1542 cm-1 and amide A peak (N-H 341 
stretching vibration) at 3292 cm-1, which are the distinguishing features of gelatin. Absorption 342 
bands at 919 cm−1 (Si-OH stretch), at 1031 cm-1 (Si-O-Si stretch), at 1160 cm-1 (Si-OH stretch) 343 
confirmed the successful GPTMS crosslinking of GL which was not affected by GS or AgNO3 344 
addition to GL solutions (reported as Supporting Information, Fig. S3). 345 
 346 
3.3 Static water contact angle 347 
17 
 
Interfacial phenomena on the GL based nanofibrous matrices were characterized by static water 348 
contact angle measurements to examine their wetting characteristics (Table 1). The electrospun 349 
GL membranes displayed a hydrophilic behavior with contact angles of about 60°. The addition 350 
of GS to GL solutions did not change the surface wettability significantly, except for GL/GS10 351 
(*p<0.05). The enhanced hydrophilicity caused by the addition of GS10 is attributed to the 352 
hydrophilic behavior of the antibiotic agent, which is more consistent for GL/GS electrospun 353 
nanofibres obtained using an amount of GS equal to 10% wt/v. On the contrary, a significant 354 
decrease in the surface hydrophilicity of the GL based nanofibres was observed by increasing the 355 
initial AgNO3 amount from 2.5 to 5 wt.% (*p<0.05) and it was probably due to the addition of 356 
hydrophobic metallic silver to the electrospun samples. 357 
 358 
Table 1. Static water contact angle of GL, GL/GS2.5, GL/GS5, GL/GS7.5, GL/GS10, 359 
GL/AgNPs2.5 and GL/AgNPs5 electrospun nanofibres. Data are reported as average values 360 
and the standard deviations. Statistical analysis was reported compared to GL nanofibers 361 
(*p<0.05). 362 
Sample Static water contact angle (°) 
GL 60.6±1.8 
GL/GS2.5 61.7±5.3 
GL/GS5 62.0±6.5 
GL/GS7.5 60.1±4.0 
GL/GS10 51.9±1.8* 
GL/AgNPs2.5 67.0±2.5* 
GL/AgNPs5 70.1±2.2* 
 363 
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3.4 Mechanical properties 364 
Tensile tests were carried out on GL electrospun nanofibres in dry conditions to determine the 365 
effect of both antibacterial agents on sample stiffness. All samples had an uniform thickness of 366 
about 100-150 µm. GL nanofibrous matrices showed an elasto-plastic behaviour; at low strains 367 
(lower than 4%) the stress increased linearly with an increase in the strain, while for strains >4% 368 
the stress increased slowly with increasing strain until failure occurred (reported as Supporting 369 
Information, Fig. S4). Table 2 shows the elastic moduli (calculated from the slope of the linear 370 
portion of the stress–strain curve, the ultimate tensile strength (UTS) and the strain at failure (ε 371 
failure) of the GL nanofibres tested in dry state. The introduction of GS or AgNO3 in GL solutions 372 
significantly increased the Young’s modulus (E) and the UTS of GL electrospun matrices loaded 373 
with an antibacterial agent compared to bare GL nanofibres. Moreover, as the blending ratio of GS 374 
or AgNO3 increased, the Young's modulus and UTS became higher. The Young’s modulus and 375 
the UTS of membranes containing AgNO3 5 wt.% was significantly different from GL/AgNP2.5 376 
and GL (**p<0.01), confirming that the reinforcing effect of the nanoparticles in the polymeric 377 
nanofibrous matrix is consistent with previously reported results [56]. A significant increase of the 378 
Young’s modulus was also observed for GS loaded samples compared to control (*p<0.05). The 379 
reinforcement features of the GS-doped nanofibres can be ascribed to the homogenous distribution 380 
of GS confirmed by EDS analysis which excluded the formation of GS aggregates as well as to 381 
the nanofibres fabrication process which loaded GS into the nanofibres bulk.  382 
A reduction of ε failure was measured when the amount of antibacterial agent increased suggesting 383 
improvement of the rigid behavior of the antibacterial nanofibres compared to bare GL nanofibres. 384 
 385 
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Table 2. Elastic modulus calculated from the elastic region of the corresponding stress-strain 386 
curves of wet GL-based nanofibrous matrices (average value ± standard deviation), *p<0.05 387 
and **p<0.01. 388 
389 
Sample E(MPa)  UTS (MPa) ε failure (%) 
GL 6.1±2.7 0.26±0.07 7.5±1.2 
GL/GS2.5 10.4±1.7* 0.39±0.08 7.2±1.1 
GL/GS5 12.6±2.0* 0.50±0.1** 5.9±0.9* 
GL/GS7.5 12.4±2.3* 0.48±0.09** 5.6±1.1* 
GL/GS10 13.2±3.8* 0.62±0.04** 4.4±1.2** 
GL/AgNPs2.5 8.1±1.2 0.32±0.08 6.1±0.9* 
GL/AgNPs5 22.2±2.1** 0.55±0.09** 2.8±1.1** 
 390 
 391 
3.5 Antibacterial agent release quantification 392 
The GS release from GL nanofibres was evaluated in vitro by quantifying the amount of GS in the 393 
collected medium after different time periods. Fig. 3A shows the release kinetics of GS from 394 
nanofibrous matrices after 1, 3, 6, 9 and 24 h of incubation in PBS using UV–visible spectroscopy. 395 
The results revealed that all electrospun samples released a quick burst of antibiotic in the first 3 396 
hours, with magnitude increasing with drug loading content. For longer exposure times, minimal 397 
drug release was observed for all samples. A rapid release of antibacterial agents during the first 3 398 
hours would kill most of the pathogens, whereas a slow and constant release over the following 399 
hours would avoid re-colonization during the healing process. 400 
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The Ag+ ion release was measured though ICP-AES analysis which revealed a burst release of 401 
ions in the first hours as observed for GS (Fig. 3B). On the contrary, a sustained release was 402 
measured in the following days up to 7 days, confirming the long-lasting antibacterial effect of the 403 
GL/AgNPs nanofibers. 404 
 405 
Fig. 3. (A) Cumulative release of GS from electrospun GL/GS2.5, GL/GS5, GL/GS7.5 and 406 
GL/GS10 blends. The GS release concentration was reported as a percentage respect to the 407 
initial concentration into the GL nanofibres. (B) Cumulative release of silver ions from 408 
electrospun GL/AgNPs2.5 e GL/AgNPs5. 409 
 410 
3.6 Antibacterial activity of GL/GS and GL/AgNPs nanofibres 411 
3.6.1 Disk diffusion method 412 
The antibacterial activity of nanofibrous membranes against Gram-positive S. aureus, S. 413 
epidermidis and Gram-negative P. aeruginosa and E. coli was firstly tested by diffusion method. 414 
After 24 h of incubation at 37°C, composite nanofibres loaded with GS or AgNPs presented a clear 415 
zone of inhibition around the fibre mat and confirmed the antibacterial activity against all the 416 
bacteria (Fig. 4). GL nanofibrous membranes had no antibacterial activity against all the tested 417 
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strains whereas GL/GS2.5 was ineffective only against P. aeruginosa. GL/GS5, GL/GS7.5, 418 
GL/GS10 and GL/AgNO3 (GL/AgNPs2.5 and GL/AgNPs5) nanofibrous membranes were 419 
effective both against Gram-positive and Gram-negative strains in a dose-concentration manner.420 
 421 
Fig.4 Images of the inhibition zones for GL based nanofibres: (A) drug-free GL, (B) 422 
GL/GS2.5, (C) GL/GS5, (D) GL/GS7.5, (E) GL/GS10, (F) drug-free GL, (G) GL/AgNPs2.5 423 
and (H) GL/AgNPs5. 424 
 425 
 426 
 427 
 428 
 429 
3.6.2 MTT colorimetric assay 430 
The antibacterial activity of 2 mg of each sample was quantified by means of the MTT assay up 431 
to 72 hours. Fig. 5 shows the differences in metabolic activity of cells co-incubated for 24 hours 432 
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with nanofibrous membranes. In comparison to GL fibres, GL/GS and GL/AgNO3 samples 433 
significantly reduced cell growth of all tested strains (p<0.001). In particular, S. aureus and S. 434 
epidermidis were inhibited averagely by 97%, E. coli by 98 % and P. aeruginosa, the less 435 
susceptible, by 93 %. 436 
 437 
Fig.5. Metabolic activity measured by MTT assay of 4 different strains incubated for 24h 438 
with nanofibrous membranes loading different amount of GS (A) and Ag (B). Statistical 439 
analysis is referred to the comparison between the different nanofibres and the control at the 440 
same time point (*** p<0.001). 441 
After 48 and 72 hours of incubation, the antibacterial effect of GL/GS and GL/AgNO3 nanofibrous 442 
membranes was confirmed by inhibition percentages > 98.5% for all the tested strains with the 443 
exception of P. aeruginosa co-incubated with GL/GS 2,5%, which was reduced by 95% (p<0.001) 444 
(reported as Supporting Information, Fig. S5). 445 
 446 
3.7 Cellular test 447 
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NHDF-Neo were seeded onto the surface of the nanofibres membranes containing silver and 448 
gentamicin at different concentrations in order to evaluate the biological properties of these 449 
systems. Cell viability was evaluated by live/dead staining assay after 24 and 48 hours of 450 
incubation, as shown in Fig. 6. The bare GL membranes showed a high cell viability and ability to 451 
promote cell attachment. On the other hand, the presence of antibacterial agents affected the cell 452 
behavior when a threshold concentration was exceeded. Particularly, it was found that the addition 453 
of gentamicin to GL membranes (for both concentrations 2.5 and 10 %w/v) maintained the good 454 
cell viability observed on cells cultured on tissue culture plate TCP and GL samples. As shown in 455 
Fig. 6 (C-D) by the Live/dead and metabolic activity assays, cell viability was maintained and cell 456 
growth was enhanced after 48 hours. NHDF-Neo exhibited their typically flattened and elongated 457 
morphology on both membranes and spreading homogeneously along the sample surface. On the 458 
other hand, silver-loaded membranes, for both concentrations at 2.5 and 5 % w/v, evidenced lower 459 
cytocompatibility compared with GL and gentamicin-loaded samples.  460 
The metabolic activity of NHDF-Neo was evaluated using Presto Blue assay (Fig. 7) up to 4 days. 461 
NHDF-Neo metabolic activity revealed a significant increase at each time point by incorporating 462 
gentamicin within the GL membranes in both concentrations, confirming the results observed by 463 
the live/dead staining assay. Interestingly, the GL/GS10 induced the highest fibroblasts metabolic 464 
activity when compared to GL and GL/GS2.5 (p<0.001). The GS-loaded samples stimulated the 465 
cell growth and promoted a faster fibroblasts spreading. 466 
In contrast to GS, a significant viability reduction was observed on nanofibrous membranes loaded 467 
with silver, as previously described for Live/Dead analysis. After 24 hours, a reduction of 50% 468 
compared to control was observed, however cells were able to proliferate after this initial 469 
cytotoxicity and to achieve a proliferation rate comparable to control after 4 days [59, 60]. In terms 470 
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of cell morphology, cell maintained spindle-shape and grow attached to GL substrates in the 471 
presence of GS in the presence of low concentrations of AgNPs, while cells at higher 472 
concentrations of AgNPs evidenced a rounded shape and cellular contraction with smaller nucleus 473 
(Fig. 8). This can be ascribed to a cytotoxic effect of AgNPs confirmed by Live/Dead staining and 474 
low metabolic activity detected by Presto Blue assay. 475 
 476 
Fig.6 Live/Dead assay of cells seeded on membrane surfaces. Representative fluorescent 477 
micrographs of live (green) and dead (red) cells seeded on GL based nanofibres after 24 and 478 
48 hours: (A) TCP, (B) drug-free GL, (C) GL/GS2.5, (D) GL/GS10, (E) GL/AgNPs2.5 and 479 
(F) GL/AgNPs5. Scale bars= 500 µm. 480 
 481 
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Fig.7 PrestoBlue assay of cells cultured on based nanofibres after 1 and 4 days. Statistical 482 
analysis is referred to TCP at the same time point (* p<0.05, ** p<0.01, *** p<0.001). 483 
 484 
Fig.8 Fluorescence microscopy of cells seeded on membrane surfaces. Representative 485 
fluorescent micrographs of cell morphology (nucleus stained with DAPI in blue, and actin 486 
filaments stained by Rhodamine in red) on GL based nanofibres after 48 hours: (A) drug-487 
free GL, (B) GL/GS2.5, (C) GL/GS10, (D) GL/AgNPs2.5 and (E) GL/AgNPs5. Scale bars= 488 
50 µm. 489 
 490 
 491 
Discussion 492 
 493 
An appropriate and ideal wound dressing should allow to (1) reduce infection and pain, (2) enhance 494 
the restoration of epithelial tissue, (3) be biocompatible, (4) prevent excessive fluid loss, and (5) 495 
preserve a moist environment for healing. Among others, electrospun matrices offer the unique 496 
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opportunity to combine a biomimetic, ECM-like and highly permeable substrate able to enhance 497 
tissue regeneration, with antibacterial agents to contrast bacteria adhesion and proliferation and 498 
consequently, to avoid the risk of infection during the wound healing process[61]. The possibility 499 
to fabricate ECM-like substrates is grounded in the design of the fabrication protocol which should 500 
reduce (and ideally avoid) the damage of the natural material structure in order to not compromise 501 
the interaction with cells. In this work, electrospun gelatin nanofibres with antibacterial properties 502 
were produced using an environmental and cell friendly method where only water was used as 503 
solvent within all the process to reduce the risk of cytotoxicity due to non-physiological residues 504 
and to avoid gelatin denaturation during the fabrication process [62]. The pivotal role of scaffold 505 
composition in regulating cell adhesion and proliferation has been reported since decades [63] and 506 
ECM-derived proteins are widely used in tissue engineering approaches [64]. GL was selected due 507 
to its solubility properties, as it can be solubilized in water without the use of acidic conditions or 508 
solvents which could alter the antibacterial efficacy of the antibacterial agents and could strongly 509 
affect the biocompatibility if any residue remains entrapped into the final devices. The possibility 510 
to work without the use of aggressive and potentially cytotoxic solvents is a relevant topic in the 511 
current trends for scaffolds fabrication. Compared to the state-of-the-art [65], the novelty of this 512 
work lies in the combination of nanofibrous matrices (mimicking the morphology of the 513 
extracellular matrix) with a biomimetic polymer (gelatin) using a “green electrospinning” method 514 
avoiding the use of environmental and cellular unfriendly solvents. 515 
The nanometer-sized fibrous morphology was selected to provide a high surface area to contact 516 
with cells and bacteria resulting in both good tissue regeneration and enhanced antibacterial 517 
effectiveness. The nanofibrous structure was obtained for all the fabricated samples (Fig.1 and 518 
Fig.2) and the presence of antibacterial agents slightly modified the fibres size and distribution.  519 
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Both GS and AgNP were loaded within the GL-nanofibres as confirmed by EDS, TEM and FTIR 520 
analysis (Fig.1, Fig.2 and Fig.S3). Furthermore, GS and AgNP doped nanofibres showed 521 
anhydrophilicity within the range 50°-70° (Table 1). The hydrophilicity of biomaterials has a great 522 
influence on the adhesion and proliferation of cells and the effect of doping agents on nanofibres 523 
hydrophilicity was measured to confirm that the changes in hydrophilicity are within the optimal 524 
range for cell adhesion [54]. Moreover, for wound dressings, the higher hydrophilic properties 525 
provide several advantages such as the maintenance of moist environments, exacerbated exudates 526 
or blood adsorption, and also high water vapor permeability at the wound site [55]. Besides 527 
hydrophilicity, mechanical properties were influenced by the presence of the antibacterial agents. 528 
A reinforcement of the nanofibers was observed when 10% GS and 2.5% and 5% AgNPs were 529 
added (Table 2 ND Fig. S4). 530 
Both GS and Ag were released after soaking into aqueous environment. A burst release was 531 
observed within the first three hours (Fig.3) for both the antibacterial agents. Then, the GS reached 532 
a maximum within 24 hours while Ag+ was released up to 7 days confirming a more prolonged 533 
antibacterial effect for AgNPs doped nanofibers. As reported in literature, GS is one of the most 534 
important antibiotics used for different applications, mainly for the treatment of osteomyelitis and 535 
wound healing [57]. In order to achieve the effect of antibiosis, the local concentration of 536 
gentamicin should be released constantly and above 32 mg/mL [58]. Therefore, a local delivery 537 
system of gentamicin should be designed to maintain the effective concentration to treat wounds 538 
as reported in this in vitro work. 539 
The release of these agents conferred antibacterial activity against bacterial strains usually found 540 
in infected wounds namely S. aureus, S. epidermidis, P. aeruginosa and E. coli (Fig. 4, Fig. 5 and 541 
Fig. S5). Few systems based on electrospun membranes have been reported to offer a unique 542 
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combination of the inherent properties, such as promoting cell proliferation, and simultaneously 543 
provide anesthetic and antibiotic activity for pain relief and healing [66]. However the antibiotics 544 
content should be evaluated carefully, because it may tackle the epithelial regeneration [67]. 545 
Considering this challenge, in vitro tests were performed using NHDF-Neo to analyse the effect 546 
of each antibacterial agent on cell viability and morphology. Gelatin-based substrate has been 547 
reported to favour cellular adhesion, due to the presence of cell-binding motifs (i.e. RGD) in gelatin 548 
that mediate cell-substrate interactions [68] as well as the presence of interconnected pores and the 549 
rough surface created by the nanofibrous membrane structure that allows to support the 550 
proliferation and quicker regeneration of cells [8]. However, the addition of the antibacterial drugs 551 
could affect the cellular behavior as cytotoxic effect has been reported for certain amounts of the 552 
antibacterial agents [69, 70]. In our work, GS loading amount does not affect the viability and 553 
morphology of neonatal normal human dermal fibroblasts in the presence of all the concentrations 554 
tested. However a reduction of cell viability was observed for Ag loading samples after 24 hours. 555 
These findings were supported by the ICP analysis which revealed an initial burst release of Ag+ 556 
which could overcome the biocompatibility threshold of silver. It is generally accepted assumption 557 
that the bactericidal amount of silver may have toxic effects to the cells (mainly towards 558 
prokaryotes than mammalian cells) [59, 60]. Although a slight cytotoxicity after 24h was observed, 559 
results at 4 days showed an increase in cell number and a proliferation rate comparable to the 560 
control confirming the ability of the nanofibrous matrices to support proliferation even if an initial 561 
viability reduction occurred probably ascribed to a reduction of cell adhesion when Ag was loaded 562 
into the nanofibrous mats. Interestingly, NHDF-Neo cell maintained and spindle-shape when 563 
cultured on GL substrates in the presence of GS and low concentrations of AgNPs confirming the 564 
effect of the nanostructured topography on cell arrangement.  565 
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 566 
Conclusion 567 
 568 
Electrospun gelatin nanofibres with antibacterial properties were produced to avoid the risk of 569 
infection during the wound healing process. Reported data confirmed the ECM-like morphology 570 
of the nanostructured matrices which is a key aspect for cell adhesion and tissue regeneration. 571 
Furthermore, the antibacterial agents loaded into the nanofibrous mats are efficient against Gram-572 
positive S. aureus, S. epidermidis and Gram-negative P. aeruginosa, E. coli bacteria. In 573 
conclusion, the developed matrices are promising membranes for application in wound healing 574 
thanks to the dual features combining support to tissue growth and antibacterial properties. Future 575 
work will be addressed to analyze the versatility to the proposed approach combining different 576 
antibacterial agents to achieve a multi-strains antibacterial effect. Furthermore, biomolecules (e.g. 577 
growth factors) able to enhance the regeneration process will be loaded into the developed 578 
nanofibers with limited risks of biomolecules denaturation thanks to the “green electrospinning 579 
approach” based on highly biocompatible process conditions.  580 
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